MEDSENSE - Company finances
|
EUR
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 40,296 | 105,922 | 176,084 |
| Profit before tax | 1,168 | 2,697 | 10,056 |
| Net profit | 1,110 | 2,554 | 9,453 |
| Equity | 1,111 | 3,665 | 13,118 |
| Liabilities | 12,681 | 16,006 | 31,135 |
| Non-current assets | 0 | 4,195 | 20,002 |
| Current assets | 13,792 | 15,476 | 24,251 |
| Total assets | 13,792 | 19,671 | 44,253 |
|
Taxes paid
|
|||
| STI taxes | 50 | 2,446 | 12,022 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +162.9% | +66.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.0% | 13.0% | 21.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.9% | 69.7% | 72.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.8% | 2.4% | 5.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.9% | 2.5% | 5.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 11.4 | 4.4 | 2.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDSENSE - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-01 | 2026-08-07 | 80.48 |
| 2026-06-02 | 2026-06-30 | 241.44 |
| 2026-05-03 | 2026-06-01 | 160.96 |
| 2026-03-03 | 2026-04-30 | 80.48 |
| 2026-01-01 | 2026-01-31 | 217.35 |
| 2025-12-02 | 2025-12-31 | 144.90 |
| 2025-11-01 | 2025-12-01 | 72.45 |
| 2025-09-02 | 2025-09-30 | 72.45 |
| 2025-07-01 | 2025-07-31 | 72.45 |
| 2025-05-04 | 2025-05-31 | 144.90 |
| 2025-04-01 | 2025-04-30 | 72.45 |
MEDSENSE - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company MEDSENSE is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 0.73 |
| 2026-08-31 | 2026-08-31 | 0.23 |
| 2026-06-28 | 2026-07-26 | 0.2 |
| 2025-10-30 | 2025-11-25 | 0.2 |
| 2025-08-28 | 2025-09-03 | 0.11 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDSENSE, MB (company code 306186963) is a Small partnership operating in beauty care and other beauty treatment activities. In 2025, the company generated revenue of €176.1K and net profit of €9.5K, with a profit margin of 5.4%. Revenue increased by 66.2% year on year and by 337.0% over two years, showing a clear upward trajectory from €40.3K in 2023 and €105.9K in 2024. Net profit also improved from €1.1K in 2023 to €2.6K in 2024 and €9.5K in 2025. The balance sheet expanded alongside operations: total assets reached €44.3K at the end of 2025, compared with €13.8K in 2023 and €19.7K in 2024. Equity rose to €13.1K, while liabilities increased to €31.1K. The latest ratios indicate efficient asset use, with asset turnover at 3.98x, and solid profitability relative to the asset base, reflected in ROA of 21.4% and ROE of 72.1%. Debt-to-equity stood at 2.37, indicating leverage above equity.